Moderna Submits COVID-19 Vaccine Booster Data for FDA Review
A single 50µg dose of mRNA-1273 given as a booster increased neutralizing antibody titer responses above the phase 3 benchmark.
Diana Ernst, RPh
Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.
